Bullous Pemphigus: A Comprehensive Review of a Complex Autoimmune Disease of the Skin and Mucous Membranes

Main Article Content

Paola Daniela Guerrero Ramírez
Vannia Magdalena Araujo Galaviz
Marisol Deleón Rodríguez
Nancy Marysol Guevara Hernández
Martha Yanelly Espinoza Hernández

Abstract

Pemphigus bullosus, also known as pemphigus vulgaris, is a rare and potentially serious autoimmune disease affecting the skin and mucous membranes, characterized by the formation of intraepidermal blisters due to the loss of cellular cohesion at desmosomal junctions. In this article, we present a comprehensive review of the entity, covering its epidemiology, etiopathogenesis, clinical manifestations, diagnosis and therapeutic options. We highlight the complexity and diagnostic challenges associated with bullous pemphigus, emphasizing the importance of careful clinicopathologic and immunofluorescent correlation for its proper identification.


We also discuss in detail the multidisciplinary therapeutic approach required to achieve disease control, emphasizing the use of systemic immunosuppressants and biological therapies. In addition, we highlight the relevance of local therapy and care management, along with the need for close medical follow-up to assess response to treatment and minimize adverse effects. Finally, we highlight the importance of continued research in this complex clinical entity, in order to improve the understanding of its immunopathological mechanisms and to develop more specific and personalized therapies. In conclusion, this article provides a comprehensive and updated view of bullous pemphigus, with the aim of improving its clinical management and promoting a more efficient and effective therapeutic approach.

Article Details

How to Cite
Ramírez, P. D. G., Araujo Galaviz, V. M., Rodríguez, M. D. ., Guevara Hernández , N. M. ., & Espinoza Hernández, M. Y. . (2023). Bullous Pemphigus: A Comprehensive Review of a Complex Autoimmune Disease of the Skin and Mucous Membranes. International Journal of Medical Science and Clinical Research Studies, 3(8), 1582–1586. https://doi.org/10.47191/ijmscrs/v3-i8-25
Section
Articles

References

I. B.S. Daniel, L. Borradori, R.P. Hall 3rd, D.F. Murrell. Evidence-based management of bullous pemphigoid. Dermatol Clin, 29 (2011), pp. 613-620 http://dx.doi.org/10.1016/j.det.2011.06.003

II. D.F. Mutasim.Autoimmune bullous dermatoses in the elderly: an update on , diagnosis and management. Drugs Aging, 1 (2010), pp. 1-19.

III. G. Di Zenzo, G. Marazza, L. Borradori. Bullous pemphigoid: physiopathology, clinical features and management. Adv Dermatol, 23 (2007), pp. 257-288.

IV. G. Kirtschig, N.P. Khumalo. Management of bullous pemphigoid: recommendations for immunomodulatory treatments. Am J Clin Dermatol, 5 (2004), pp. 319-326.

V. S.M. Langan, L. Smeeth, R. Hubbard, K.M. Fleming, C.J. Smith, J. West. Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study. BMJ, 337 (2008), pp. A180.

VI. P. Joly, S. Baricault, A. Sparsa, P. Bernard, C. Bédane, S. Duvert-Lehembre, et al. Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol, 132 (2012), pp. 1998-2004 http://dx.doi.org/10.1038/jid.2012.35

VII. V.A. Venning, F. Wojnarowska.The association of bullous pemphigoid and malignant disease: a case control study. Br J Dermatol, 123 (1990), pp. 439-445.

VIII. J.A. Fairley, C.T. Burnett, C.L. Fu, D.L. Larson, M.G. Fleming, G.J. Giudice. A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice. J Invest Dermatol, 127 (2007), pp. 2605-2611 http://dx.doi.org/10.1038/sj.jid.5700958

IX. J.J. Zone, T. Taylor, C. Hull, L. Schmidt, L. Meyer. IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice. J Invest Dermatol, 127 (2007), pp. 1167-1174 http://dx.doi.org/10.1038/sj.jid.5700681

X. D.T. Woodley. The role of IgE anti-basement membrane zone autoantibodies in bullous pemphigoid. Arch Dermatol, 143 (2007), pp. 249-250 http://dx.doi.org/10.1001/archderm.143.2.249

XI. Y. Iwata, K. Komura, M. Kodera, T. Usuda, Y. Yokoyama, T. Hara, et al. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid. Arch Dermatol, 144 (2008), pp. 41-48 http://dx.doi.org/10.1001/archdermatol.2007.9

XII. L. Vaillant, P. Bernard, P. Joly, C. Prost, B. Labeille, C. Bedane, et al. Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol, 134 (1998), pp. 1075-1080.

XIII. R.M. Vodegel, M.C. de Jong, H.J. Meijer, M.B. Weytingh, H.H. Pas, M.F. Jonkman. Enhanced diagnostic immunofluorescence using biopsies transported in saline.BMC Dermatol, 4 (2004), pp. 10http://dx.doi.org/10.1186/1471-5945-4-10

XIV. S.A. Vaughan Jones, J. Salas, J.A. McGrath, I. Palmer, G.S. Bhogal, M.M. Black. A retrospective analysis of tissue-fixed immunoreactants from skin biopsies maintained in Michel's medium. Dermatology, 189 (1994), pp. 131-132.

XV. R.M. Vodegel, M.F. Jonkman, H.H. Pas, M.C. de Jong. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol, 151 (2004), pp. 112-118. http://dx.doi.org/10.1111/j.1365-2133.2004.06006.x

XVI. N. Domloge-Hultsch, P. Bisalbutra, W.R. Gammon, K.B. Yancey. Direct immunofluorescence microscopy of 1mol/L sodium chloride-treated patient skin. J Am Acad Dermatol, 24 (1991), pp. 946-951.